Align Technology, Inc. (ALGN) vs Madrigal Pharmaceuticals, Inc. (MDGL)

A side-by-side comparison of Align Technology, Inc. and Madrigal Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 5, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGN vs MDGL

growth of $100 · dividends reinvested · last 10y
ALGN +52.2% (+4.3%/yr)MDGL +2930.2% (+40.7%/yr)MDGL compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$152$3,030
ALGN MDGL

ALGN vs MDGL: by the numbers

  • •MDGL is the larger company ($11.58B vs $10.21B market cap).
  • •ALGN is profitable (9.99% net margin) while MDGL runs a net loss (-25.32%).

Metrics side by side

Valuation

MetricALGNMDGL
P/E ratio24.76N/A
Forward P/E12.63N/A
P/S ratio2.479.02
P/B ratio2.4122.12
EV / EBITDA11.45N/A

Profitability

MetricALGNMDGL
Gross margin66.48%91.48%
Operating margin13.33%-25.13%
Net margin9.99%-25.32%
ROE9.77%-62.07%
ROIC8.90%-37.02%

Growth (annualized)

MetricALGNMDGL
Revenue CAGR (5Y)3.57%N/A
EPS CAGR (5Y)-24.16%N/A
Total return CAGR (5Y)-26.34%44.41%

Some values include inputs from SEC filing.

Frequently asked

Is ALGN or MDGL more profitable?
ALGN runs the higher net margin — ALGN at 9.99% versus MDGL at -25.32%.
How have ALGN and MDGL total returns compared?
Over the past 10 years, ALGN delivered 4.63% and MDGL delivered 41.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 5, 2026.